Table 1.
The demographics and baseline data of the participants in the normal group and osteoporosis group (mean and standard deviation).
| Variables | Normal group (n = 40) | Osteoporosis group (n = 45) |
|---|---|---|
| Age (years) | 60.9 ± 6.4 | 64.5 ± 7.6a |
| Years since menopause (years) | 9.8 ± 2.1 | 12.4 ± 2.8c |
| BMI (kg/m2) | 22.6 ± 3.3 | 22.1 ± 2.9 |
| IL-6 (IU/ml) | 0.15 ± 0.08 | 0.21 ± 0.09b |
| PTH (pg/ml) | 29.4 ± 6.3 | 32.6 ± 7.1a |
| 1,25(OH)2D3 (pg/ml) | 26.3 ± 5.8 | 25.8 ± 4.7 |
| OST (ng/ml) | 7.3 ± 2.6 | 7.9 ± 3.1 |
| IGF-1 (ng/ml) | 178.5 ± 54.8 | 157.3 ± 45.9 |
| IGFBP-3 (μg/ml) | 3.36 ± 0.56 | 3.87 ± 0.68c |
| LS BMD (g/cm2) | 0.712 ± 0.108 | 0.636 ± 0.114b |
| FN BMD (g/cm2) | 0.623 ± 0.086 | 0.568 ± 0.092b |
Significant at ap < 0.05, bp < 0.01, and cp < 0.001. BMI: body mass index; IL-6: interleukin 6; PTH: parathyroid hormone; OST: osteocalcin; LS: lumbar spine; FN: femoral neck.